Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
The current price of MAHLY is $20.10 USD — it has increased by +0.05% in the past 24 hours. Watch Medipal stock price performance more closely on the chart.
What is Medipal stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Medipal stocks are traded under the ticker MAHLY.
Is Medipal stock price growing?▼
MAHLY stock has risen by +1.46% compared to the previous week, the month change is a +4.91% rise, over the last year Medipal has showed a +25.78% increase.
What is Medipal market cap?▼
Today Medipal has the market capitalization of 4.34B
When is the next Medipal earnings date?▼
Medipal is going to release the next earnings report on February 3, 2027.
What were Medipal earnings last quarter?▼
MAHLY earnings for the last quarter are 0.29 USD per share, whereas the estimation was 0.44 USD resulting in a -34.58% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medipal revenue for the last year?▼
Medipal revenue for the last year amounts to 25.13B USD.
What is Medipal net income for the last year?▼
MAHLY net income for the last year is 280.83M USD.
Does Medipal pay dividends?▼
Yes, MAHLY dividends are paid semi-annual. The last dividend per share was 0.21 . As of today, Dividend Yield (FWD)% is 2.08%.
How many employees does Medipal have?▼
As of November 7, 2026, the company has 13,024 employees.